Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results
Augustin, M.; Dauden, E.; Mrowietz, U.; Konstantinou, M. P.; Gerdes, S.; Kingo, K.; Szepietowski, J. C.; Perrot, J. L.; Cuccia, A.; Rissler, M.; Gathmann, S.; Sieder, C.; Orsenigo, R.; Jagiello, P.; Bachhuber, T. (2020). Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.16632.
artikkel ajakirjas
Augustin, M.; Dauden, E.; Mrowietz, U.; Konstantinou, M. P.; Gerdes, S.; Kingo, K.; Szepietowski, J. C.; Perrot, J. L.; Cuccia, A.; Rissler, M.; Gathmann, S.; Sieder, C.; Orsenigo, R.; Jagiello, P.; Bachhuber, T.
- Inglise
Journal of the European Academy of Dermatology and Venereology
HOBOKEN
0926-9959
2020
10
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index, Emerging Sources Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
Jah
hübriid
Autorile viitamine – Mitteäriline eesmärk – Tuletatud teoste keeld (CC BY-NC-ND)
WOS
Viited terviktekstile
Seotud asutused
Lisainfo
Article
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.16632